EUDA
EUDA Health Holdings Ltd
$
2.590
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.590
Open
2.590
VWAP
2.59
Vol
38.00
Mkt Cap
96.24M
Low
2.590
Amount
98.42
EV/EBITDA(TTM)
--
Total Shares
35.13M
EV
97.05M
EV/OCF(TTM)
--
P/S(TTM)
19.95
EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required.
Show More
Valuation Metrics
The current forward P/E ratio for EUDA Health Holdings Ltd (EUDA.O) is -22.91, compared to its 5-year average forward P/E of -17.80. For a more detailed relative valuation and DCF analysis to assess EUDA Health Holdings Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-17.80
Current PE
-22.91
Overvalued PE
3.60
Undervalued PE
-39.21
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-4.68
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.06
Undervalued EV/EBITDA
-10.43
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
7.50
Current PS
6.82
Overvalued PS
13.46
Undervalued PS
1.55
Financials
Annual
Quarterly
FY2023Q2
YoY :
-95.71%
104.28K
Total Revenue
FY2023Q2
YoY :
-57.42%
-738.97K
Operating Profit
FY2023Q2
YoY :
+156.73%
-4.78M
Net Income after Tax
FY2023Q2
YoY :
+750.00%
-0.51
EPS - Diluted
FY2023Q2
YoY :
+109.17%
-2.04M
Free Cash Flow
FY2024Q4
YoY :
-16.36%
18.82
Gross Profit Margin - %
FY2024Q4
YoY :
-38.43%
-53.39
FCF Margin - %
FY2024Q4
YoY :
+93.23%
-439.73
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
EUDA News & Events
Events Timeline
2025-04-24 (ET)
2025-04-24
07:11:41
EUDA Health partners with Guangdong Cell Biotech
2024-12-16 (ET)
2024-12-16
16:02:18
EUDA Health, Guangdong Cell Biotech explore potential strategic partnership
Sign Up For More Events
Sign Up For More Events
News
7.5
04-24NewsfilterEUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia
7.5
2024-12-16NewsfilterEUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation
1.0
2024-10-30GlobenewswireNRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
Sign Up For More News
People Also Watch
DTI
Drilling Tools International Corp
1.990
USD
-0.50%
OPOF
Old Point Financial Corp
41.480
USD
0.00%
NYMTL
New York Mortgage Trust Inc
21.970
USD
0.00%
MNSB
MainStreet Bancshares Inc
21.910
USD
+2.24%
VGAS
Verde Clean Fuels Inc
2.880
USD
0.00%
LCTX
Lineage Cell Therapeutics Inc
1.005
USD
-0.50%
HURC
Hurco Companies Inc
18.660
USD
-0.90%
ANRO
Alto Neuroscience Inc
3.160
USD
-0.63%
FAQ
What is EUDA Health Holdings Ltd (EUDA) stock price today?
The current price of EUDA is 2.59 USD — it has increased 0 % in the last trading day.
What is EUDA Health Holdings Ltd (EUDA)'s business?
What is the price predicton of EUDA Stock?
What is EUDA Health Holdings Ltd (EUDA)'s revenue for the last quarter?
What is EUDA Health Holdings Ltd (EUDA)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for EUDA Health Holdings Ltd (EUDA)'s fundamentals?
How many employees does EUDA Health Holdings Ltd (EUDA). have?